Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancer

ABSTRACT: We performed RNA-seq to evaluate the consequence of saracatinib's effects on androgen receptor residue Y534 as it pertains to Androgen Receptor gene signatures

ORGANISM(S): Homo sapiens

PROVIDER: GSE229805 | GEO | 2023/04/20

REPOSITORIES: GEO